![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-5992|17|2|212-220
ISSN: 1871-5206
Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.17, Iss.2, 2017-01, pp. : 212-220
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reduction of BRCA1 Expression in Sporadic Ovarian Cancer
By Zheng W. Luo F. Lu J.J. Baltayan A. Press M.F. Zhang Z.-F. Pike M.C.
Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Hautala Laura Greco Dario Koistinen Riitta Heikkinen Tuomas Heikkilä Päivi Aittomäki Kristiina Blomqvist Carl Koistinen Hannu Nevanlinna Heli
Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
BRCA1 and BRCA2 in breast cancer
Breast Cancer Research and Treatment, Vol. 54, Iss. 1, 1999-03 ,pp. :